Navigation Links
Patient management: Quality of life and beyond

SAN ANTONIO - Breast cancer is a multifaceted disease requiring creative solutions for diagnosis, quality of life management and adjuvant therapies. Data presented at the CTRC-AACR San Antonio Breast Cancer Symposium explore these areas.

Hormone Supplements Reduce Death from Breast Cancer
Abstract #65, Sarah Marshall, M.A.

Although hormone supplements have been implicated in increased rates of breast cancer, they appear to mitigate the mortality risk of breast cancers that do develop. Compared with women who did not use hormone therapy, women who took estrogen-progestin were 63 percent less likely to die from breast cancer while those who took estrogen alone were 30 percent less likely.

Full release available/Complete data to be presented at the meeting.

Tamoxifen Tops Anastrazole for Quality of Life, but not Survival
Abstract #1136, Shozo Ohsumi, M.D., Ph.D.
Embargo: 5:30 p.m. CST, December 11, 2008

After one to four years of tamoxifen, switching to anastrozole improves disease-free survival by about 31 percent, but patients pay a price in quality of life measures. The difference in quality of life is significant enough that scientists say it should be considered, and may even be the deciding factor, when making a clinical decision about therapeutic strategy.

Full release available/Complete data to be presented at the meeting.

Letrozole following breast cancer surgery may provide survival benefit
Abstract #13, Alan Coates, M.D.
Embargo: 9:45 a.m. CST, December 11, 2008

Letrozole may improve overall survival in patients with primary breast cancer. A four-arm comparison study of letrozole and tamoxifen shows letrozole not only reduces recurrence, but may provide a 13 percent reduction in risk of death. Additionally, the study finds that using a sequence of tamoxifen and letrozole is not superior to letrozole alone. The sequence of letrozole followed by tamoxifen was closely similar to letrozole alone implying that patients can safely switch to tamoxifen after initial letrozole if required.

Complete data to be presented at the meeting.

Use of Written Forms Doubles Breast Cancer Detection Rate
Abstract #5012, William Goodson, M.D.

When clinicians used simple written forms to focus attention during clinical breast exams, the rate of breast mass detection from the previous year doubled without retraining clinicians, thus affirming the importance of clinician attentiveness. This finding, researchers say, can be applied to all aspects of medicine and undermines the need for intensive training, complicated techniques, and medical reimbursement codes to improve this simple, yet valuable procedure.

Complete data to be presented at the meeting.


Contact: Jeremy Moore
American Association for Cancer Research

Related medicine news :

1. Risk Info for Breast Cancer Patients Too Confusing
2. Combo Therapy Helps Multiple Myeloma Patients
3. Prescription Drug Benefits for Medicare Patients with Cancer to Cost More in 2009
4. Early stage, HER2-positive breast cancer patients at increased risk of recurrence
5. Patient Care Means Employee Care at Illinois Hospitals
6. 2 Markers Predict Survival Odds in Colon Cancer Patients
7. Hallmark Hall of Fame Collaboration with Patient Organization Equals Extraordinary Success
8. Nursing Data on Patient Safety in California Will Expand to Include Two Pacific Northwest States
9. Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care
10. LegalView Reports That Skin Cancer Drug May Offer Treatment to Mesothelioma Patients
11. Michigan Governors Executive Order Budget Cuts Do Not Cut Payments to Medicaid Patients
Post Your Comments:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
Breaking Medicine Technology: